This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Pésci Tudományegyetem. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Ferenc Gallyas, Jr: Innovator in Cancer Treatment
Introduction
Ferenc Gallyas, Jr. is a notable inventor based in Pécs, Hungary. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work exemplifies the intersection of science and medicine, aiming to improve patient outcomes.
Latest Patents
Ferenc Gallyas, Jr. holds a patent for a compound known as desethylamiodarone, which is used in cancer treatment. The invention relates to desethylamiodarone and its pharmaceutically acceptable salts, hydrates, and solvates. Additionally, it includes a pharmaceutical composition comprising the compound along with a suitable excipient, vehicle, or carrier for effective cancer treatment. This patent highlights his commitment to advancing medical therapies.
Career Highlights
Throughout his career, Gallyas has worked with esteemed institutions, including Pécsi Tudományegyetem and Pécsi Tudományegyetem. His experience in these academic environments has allowed him to collaborate with other professionals and contribute to groundbreaking research in the medical field.
Collaborations
Ferenc Gallyas, Jr. has collaborated with notable colleagues such as Balázs Sümegi and Zita Bognár. These partnerships have fostered a collaborative spirit in research, enhancing the development of innovative solutions in cancer treatment.
Conclusion
Ferenc Gallyas, Jr. is a distinguished inventor whose work in cancer treatment through the development of desethylamiodarone showcases his dedication to improving healthcare. His contributions to the field are invaluable and reflect the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile